| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6799501 | Journal of Psychiatric Research | 2018 | 8 Pages |
Abstract
This meta-analysis of 8 short-term studies supported the efficacy and safety of lurasidone in the acute phase of schizophrenia, particularly at the higher dose range of 80â¯mg/day.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Wei Zheng, Dong-Bin Cai, Xin-Hu Yang, Lu Li, Qing-E. Zhang, Chee H. Ng, Gabor S. Ungvari, Xian-Bin Li, Yu-Ping Ning, Yu-Tao Xiang,